Clinical Trials Logo
  1. Home
  2. Nonalcoholic Fatty Liver
  3. NCT03950882

A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD

Nonalcoholic Fatty Liver Clinical Trial

Official title:
A Randomized, Double-blind, Placebo-controlled Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Clinical Trial Summary

This study will assess the pharmacokinetics of PXL770 after 4 weeks of treatment.

Clinical Trial Description

The study will be performed in subjects with Nonalcoholic Fatty Liver Disease. The primary endpoint will be the assessment of PXL770 exposure in plasma. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03950882
Study type Interventional
Source Poxel SA
Contact
Status Completed
Phase Phase 1
Start date August 1, 2019
Completion date March 31, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT04031729 - Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease Phase 1/Phase 2
Recruiting NCT03725631 - Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD N/A
Active, not recruiting NCT05084404 - Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease Phase 2
Completed NCT05081427 - Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2
Recruiting NCT05430178 - Metabolic Pathology of Pediatric NAFLD N/A
Recruiting NCT04389593 - Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology as Reference
Active, not recruiting NCT05199948 - Weight, Energy, Lipids, and the Liver (WELL) Study N/A
Active, not recruiting NCT03696797 - Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease N/A
Terminated NCT02365233 - Fatty Liver Study in Patients With Type II Diabetes Phase 4
Completed NCT05309642 - Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study N/A
Completed NCT03763877 - A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD Phase 2
Completed NCT04828551 - Noninvasive Biomarkers of Metabolic Liver Disease 1.1 N/A
Completed NCT05792423 - Conditionally Increased Output (CIO) Enhanced Ultrasound System N/A
Not yet recruiting NCT06335771 - Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity N/A
Recruiting NCT02815891 - A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Not yet recruiting NCT05908877 - Cardio-Metabolic Risk Evaluation in Overweight and Obese Children
Not yet recruiting NCT04887766 - Study on GS300 on NAFLD N/A
Completed NCT03986684 - Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease
Recruiting NCT05165706 - Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance N/A
Completed NCT04235205 - Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease Phase 2